CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Qube Research & Technologies Ltd's Holding History (CIK: 0001729829)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 198,917 Value ($000) $5,721 Avg Close $30.88 Range $24.10 - $34.68
Q1 2025
Shares 429,063 Value ($000) $14,391 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 219,524 Value ($000) $11,224 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 287,794 Value ($000) $14,706 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 390,941 Value ($000) $17,510 Avg Close $46.18 Range $41.01 - $53.70
Q1 2024
Shares 94,867 Value ($000) $4,441 Avg Close $39.13 Range $33.67 - $47.58
Q4 2023
Shares 57,715 Value ($000) $2,054 Avg Close $30.67 Range $25.35 - $37.88
Q2 2023
Shares 55,798 Value ($000) $1,005 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 11,035 Value ($000) $177 Avg Close $18.51 Range $15.23 - $21.65
Q2 2022
Shares 10,798 Value ($000) $201 Avg Close $19.96 Range $15.91 - $27.86